196 related articles for article (PubMed ID: 33329712)
1. Increased NFATC4 Correlates With Poor Prognosis of AML Through Recruiting Regulatory T Cells.
Zhao C; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Shi J
Front Genet; 2020; 11():573124. PubMed ID: 33329712
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients.
Zhao C; Huang R; Zeng Z; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Yan P; Huang Z; Shi J
Aging (Albany NY); 2021 May; 13(10):14131-14158. PubMed ID: 34001679
[TBL] [Abstract][Full Text] [Related]
3. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia.
Cheng F; Li Q; Wang J; Wang L; Li W; Zeng F
Dis Markers; 2022; 2022():3199589. PubMed ID: 35280440
[TBL] [Abstract][Full Text] [Related]
4. A hypoxia-related genes prognostic risk model, and mechanisms of hypoxia contributing to poor prognosis through immune microenvironment and drug resistance in acute myeloid leukemia.
Liu X; Wang L; Kang Q; Feng C; Wang J
Front Pharmacol; 2024; 15():1339465. PubMed ID: 38482057
[No Abstract] [Full Text] [Related]
5. Integrated bioinformatic analysis of mitochondrial metabolism-related genes in acute myeloid leukemia.
Tong X; Zhou F
Front Immunol; 2023; 14():1120670. PubMed ID: 37138869
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Analysis Identifies EPAS1 as a Novel Prognostic Marker Correlated with Immune Infiltration in Acute Myeloid Leukemia.
Wang S; Zhang P
Dis Markers; 2023; 2023():6072782. PubMed ID: 37124944
[TBL] [Abstract][Full Text] [Related]
7. Collagen Type III Alpha 1 chain regulated by GATA-Binding Protein 6 affects Type II IFN response and propanoate metabolism in the recurrence of lower grade glioma.
Huang R; Li Z; Zhu X; Yan P; Song D; Yin H; Hu P; Lin R; Wu S; Meng T; Zhang J; Huang Z
J Cell Mol Med; 2020 Sep; 24(18):10803-10815. PubMed ID: 32757451
[TBL] [Abstract][Full Text] [Related]
8. SPINK2 is a prognostic biomarker related to immune infiltration in acute myeloid leukemia.
Chen X; Zhao L; Yu T; Zeng J; Chen M
Am J Transl Res; 2022; 14(1):197-210. PubMed ID: 35173838
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
[TBL] [Abstract][Full Text] [Related]
10. Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma
Huang R; Huang D; Wang S; Xian S; Liu Y; Jin M; Zhang X; Chen S; Yue X; Zhang W; Lu J; Liu H; Huang Z; Zhang H; Yin H
Front Genet; 2022; 13():952162. PubMed ID: 36092920
[No Abstract] [Full Text] [Related]
11. Identification and validation of a novel CD8+ T cell-associated prognostic model based on ferroptosis in acute myeloid leukemia.
Jiang G; Jin P; Xiao X; Shen J; Li R; Zhang Y; Li X; Xue K; Li J
Front Immunol; 2023; 14():1149513. PubMed ID: 37138885
[TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis.
He Q; Fan B; Du P; Jin Y
Front Cell Dev Biol; 2022; 10():806989. PubMed ID: 35356272
[No Abstract] [Full Text] [Related]
13. Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia.
Guo C; Ju QQ; Zhang CX; Gong M; Li ZL; Gao YY
BMC Cancer; 2020 Jun; 20(1):586. PubMed ID: 32571260
[TBL] [Abstract][Full Text] [Related]
14. Prognostic biomarker replication factor C subunit 5 and its correlation with immune infiltrates in acute myeloid leukemia.
Li WJ; Wu DW; Zhou YF; Zhang CW; Liao XW
Hematology; 2022 Dec; 27(1):555-564. PubMed ID: 35544695
[TBL] [Abstract][Full Text] [Related]
15. Prognostic characteristics of immune subtypes associated with acute myeloid leukemia and their identification in cell subsets based on single-cell sequencing analysis.
Lu J; Zheng G; Dong A; Chang X; Cao X; Liu M; Shi X; Wang C; Yang Y; Jia X
Front Cell Dev Biol; 2022; 10():990034. PubMed ID: 36211454
[TBL] [Abstract][Full Text] [Related]
16. Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia.
Zhou H; Wang F; Niu T
Front Nutr; 2022; 9():1056648. PubMed ID: 36618700
[TBL] [Abstract][Full Text] [Related]
17. Comparison of multi-omics results between patients with acute myeloid leukemia with long-term survival and healthy controls.
Song Y; Hao Q; Zhang G; Fang Q; Wang Z; Li Y; Wei H; Wang Y; Jiang E; Tian Z; Jia Y; Wang M; Wang J; Mi Y
Ann Transl Med; 2022 Jan; 10(2):82. PubMed ID: 35282130
[TBL] [Abstract][Full Text] [Related]
18. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
[No Abstract] [Full Text] [Related]
19. An inflammatory response-related gene signature associated with immune status and prognosis of acute myeloid leukemia.
Wu X; Li S; Chen D; Zheng G; Zhang Z; Li Z; Sun X; Zhao Q; Xu J
Am J Transl Res; 2022; 14(7):4898-4917. PubMed ID: 35958446
[TBL] [Abstract][Full Text] [Related]
20. Investigation of distinct gene expression profile patterns that can improve the classification of intermediate-risk prognosis in AML patients.
Eshibona N; Livesey M; Christoffels A; Bendou H
Front Genet; 2023; 14():1131159. PubMed ID: 36865386
[No Abstract] [Full Text] [Related]
[Next] [New Search]
